Trial
NCT00418821
A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Genzyme, a Sanofi Company
Collaborators
BioMarin/Genzyme LLC
Condition
Mucopolysaccharidosis I
Intervention
Laronidase
Why stopped
Study was conducted to fulfill a post marketing commitment (PMC). FDA acknowledged closure of PMC.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-20